West Announces Second-Quarter 2023 Dividend
West Pharmaceutical Services, Inc. (NYSE: WST) has announced a quarterly dividend of $0.19 per share, payable on May 3, 2023, to shareholders recorded as of April 26, 2023. This dividend reflects the company's ongoing commitment to returning value to its shareholders. In fiscal year 2022, West generated $2.89 billion in net sales, marking a significant milestone in its 100-year history of innovation in the injectable solutions market. The company supports pharmaceutical developers with reliable containment and delivery solutions, underscoring its critical role in healthcare.
- Dividend of $0.19 per share indicates strong shareholder return.
- Generated $2.89 billion in net sales in fiscal year 2022.
- Marks 100 years of innovation and leadership in the injectable solutions market.
- None.
About West
2023 marks West's 100-year milestone of innovation and the critical role it continues to play in healthcare and the patient experience. Headquartered in
© 2023
All trademarks and registered trademarks used in this release are the property of West Pharmaceutical Services, Inc. or its subsidiaries, in the United States and other jurisdictions, unless otherwise noted.
View original content to download multimedia:https://www.prnewswire.com/news-releases/west-announces-second-quarter-2023-dividend-301761743.html
SOURCE
FAQ
What is the dividend amount announced by West Pharmaceutical Services for Q2 2023?
When will the dividend be paid to shareholders?
What is the record date for the dividend payment by West Pharmaceutical Services?
How much net sales did West Pharmaceutical Services generate in 2022?